SCHEMBL27645313

SCHEMBL27645313

CCC=CCc1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.53
MAOB P27338 1/20 0.42
IDO1 P14902 4/20 0.41
AGXT P21549 2/20 0.41
SLC6A2 P23975 2/20 0.39
SLC6A3 Q01959 2/20 0.39
TAAR1 Q96RJ0 2/20 0.39
SLC6A4 P31645 2/20 0.39
HTR2A P28223 1/20 0.39
HRH1 P35367 1/20 0.39
HTR2B P41595 1/20 0.39
CHRNA4 P43681 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 1/20 0.36
CYP2A6 P11509 1/20 0.36
AOC3 Q16853 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14046063 0.94 KCNH2 (0.49) KCNH2MAOBIDO1AGXTSLC6A2
SCHEMBL14046109 0.90 KCNH2 (0.46) KCNH2MAOBIDO1AGXTSLC6A2
SCHEMBL27666030 0.83 KCNH2 (0.54) KCNH2MAOBIDO1AGXTSLC6A2
SCHEMBL9664457 0.79 KCNH2 (0.46) KCNH2MAOBIDO1AGXTSLC6A2
SCHEMBL9153358 0.79 IDO1 (0.42) KCNH2IDO1AGXTSLC6A2SLC6A3
SCHEMBL16234241 0.79 IDO1 (0.48) KCNH2MAOBIDO1AGXTSLC6A2
SCHEMBL6683227 0.79 MAOB (0.44) KCNH2MAOBIDO1AGXTTAAR1
SCHEMBL11005834 0.79 IDO1 (0.48) KCNH2MAOBIDO1AGXTSLC6A2
SCHEMBL9664449 0.79 KCNH2 (0.46) KCNH2MAOBIDO1AGXTSLC6A2
SCHEMBL1051791 0.79 MAOB (0.44) KCNH2MAOBIDO1AGXTTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed